Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAMP4 Therapeutics
Biotech
GSK pays $17.5M for CAMP4 regulatory RNA deal
GSK is paying $17.5 million upfront to collaborate on regulatory RNA-targeting therapeutics in neurodegenerative and kidney disease indications.
Nick Paul Taylor
Dec 18, 2025 7:00am
Sana, CAMP4 ditch clinical-stage assets for preclinical hopefuls
Nov 7, 2025 8:13am
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Sep 12, 2025 8:30am
Upstream swells IPO to $255M as it lists alongside CAMP4
Oct 11, 2024 5:18am
CAMP4 is latest to eye IPO, while Upstream spells out $182M plan
Oct 7, 2024 8:44am
BioMarin goes CAMPing, striking RNA deal with biotech
Oct 1, 2024 9:55am
